Woodline Partners LP Humacyte, Inc. Call Options Transaction History
Woodline Partners LP
- $13.5 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HUMA
# of Institutions
172Shares Held
41.5MCall Options Held
591KPut Options Held
872K-
Black Rock Inc. New York, NY7.14MShares$27.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$21.9 Million0.0% of portfolio
-
State Street Corp Boston, MA4.61MShares$18 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.14MShares$8.35 Million0.0% of portfolio
-
Center Book Partners LP Greenwich, CT1.28MShares$5 Million0.42% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $403M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...